Houston Methodist DeBakey Heart and Vascular Center

 

Houston Methodist DeBakey Heart and Vascular Center
Avatar

What Is the Role of Lipids and Inflammation Biomarkers in Residual Risk?

By Houston Methodist DeBakey Heart and Vascular Center FEATURING Laurence Sperling
By Houston Methodist DeBakey Heart and Vascular Center FEATURING Laurence Sperling
490 views
November 26, 2020
0 Comments
Login to view comments. Click here to Login
Clinical Cardiology
06:59
Houston Methodist DeBakey Heart and Vascular Center

Implementation of Evidence-Based Strategies for Chronic Cardiovascul…

Feat. J. Butler
50:29
Houston Methodist DeBakey Heart and Vascular Center

Imaging in Preventive Cardiology

Feat. K. Nasir
31:46
Houston Methodist DeBakey Heart and Vascular Center

Group 2 Pulmonary Hypertension: Isn't it Just Heart Failure?

Feat. H. Ali
33:50
Houston Methodist DeBakey Heart and Vascular Center

Left Ventricular Thrombosis: An Overview

Feat. Y. Saleh
42:28
Houston Methodist DeBakey Heart and Vascular Center

Treatment of Lipids in 2023: Where Are We Now and Where Are We Going?

Feat. C. Ballantyne
52:41
Houston Methodist DeBakey Heart and Vascular Center

Coronary CT Angiography in Clinical Cardiology and Prevention

Feat. R. Blankstein
12:25
Houston Methodist DeBakey Heart and Vascular Center

Preventive Cardiology as a Dedicated Service Line: The Time Is Now

Feat. M. Shapiro
15:43
Houston Methodist DeBakey Heart and Vascular Center

Women Heart Center: Evolving CVD Prevention Need Among Women

Feat. M. Gulati
09:13
Houston Methodist DeBakey Heart and Vascular Center

Future of CVD Risk Assessment & Prevention: See Disease, Treat D…

Feat. K. Nasir
18:36
Houston Methodist DeBakey Heart and Vascular Center

Top 4 Topics in Preventive Cardiology: Discussion

Feat. M. Shapiro, M. Gulati, K. Nasir
11:57
Houston Methodist DeBakey Heart and Vascular Center

How to Choose from Established and Emerging Lipid Lowering Therapies

Feat. C. Ballantyne
10:07
Houston Methodist DeBakey Heart and Vascular Center

Should Cardiometabolic Protective Agents be the First Choice for Dia…

Feat. K. Patel
13:41
Houston Methodist DeBakey Heart and Vascular Center

Practical Tips on Hypertension Management for ASCVD and Heart Failur…

Feat. S. Khan
13:20
Houston Methodist DeBakey Heart and Vascular Center

Thrombotic Balance: Underappreciated Markers for ASCVD Risk

Feat. A. Defilippis
12:10
Houston Methodist DeBakey Heart and Vascular Center

Lipids and Beyond for CVD Prevention: Discussion

Feat. C. Ballantyne, K. Patel, S. Khan, A. Defilippis
11:40
Houston Methodist DeBakey Heart and Vascular Center

Cross Talk Between Obesity, Fatty Liver and Metabolic Syndrome

Feat. D. W. Victor III
11:30
Houston Methodist DeBakey Heart and Vascular Center

Sleep Apnea, Obesity and CVD

Feat. H. Walia
19:00
Houston Methodist DeBakey Heart and Vascular Center

Early Metabolic Derangements: Time to Intervene Prior to Overt Obesi…

Feat. A. Agatston
16:15
Houston Methodist DeBakey Heart and Vascular Center

Emerging Medical Management for Obesity: The Future is Bright

Feat. M. Blaha
05:37
Houston Methodist DeBakey Heart and Vascular Center

Obesity: Next Frontier for CVD Management - Discussion

Feat. D. W. Victor III, H. Walia, A. Agatston, M. Blaha
34:21
Houston Methodist DeBakey Heart and Vascular Center

Impacting the Environment for Sustainable Cardiovascular Health

Feat. S. Rajagopalan
14:55
Houston Methodist DeBakey Heart and Vascular Center

Social Media: How to Use It to Promote CVD Prevention

Feat. M. Gulati
10:14
Houston Methodist DeBakey Heart and Vascular Center

Social Determinants of Health (SDOH) and Health Equity: CVD Preventi…

Feat. K. Nasir
16:48
Houston Methodist DeBakey Heart and Vascular Center

Preventive Cardiology Beyond The Boundaries of Health System: Discus…

Feat. S. Rajagopalan, K. Patel
56:26
Houston Methodist DeBakey Heart and Vascular Center

The Kidney and the Heart

Feat. M. Quinones, H. Ibrahim, A. Tamayo-Gutierrez, S. Adeel Ahsan, A. Guha, S. Hebert, A. Edwards, A. Kansara
51:21
Houston Methodist DeBakey Heart and Vascular Center

Power of Zero: Shaping Past, Present and Future of Cardiovascular Ri…

Feat. K. Nasir
45:22
Houston Methodist DeBakey Heart and Vascular Center

Top 10 Predictions for the Future of CVD Prevention

Feat. P. Greenland
06:35
Houston Methodist DeBakey Heart and Vascular Center

STEP Trial: Intensive Blood Pressure Management Vs Standard Blood Pr…

Feat. D. Tientcheu
08:54
Houston Methodist DeBakey Heart and Vascular Center

Updates in Hypertension Management: The Use of Thiazide Diuretics to…

Feat. W. Vongpatanasin
07:58
Houston Methodist DeBakey Heart and Vascular Center

Effect of Salt Substitution on Cardiovascular Events and Death

Feat. L. Laffin
08:05
Houston Methodist DeBakey Heart and Vascular Center

Aspirin: Not a "Wonder Drug" Anymore?

Feat. M. Cainzos-Achirica
13:36
Houston Methodist DeBakey Heart and Vascular Center

Plaque, Thrombosis and Bleeding Risk: Use of Antiplatelet Therapy

Feat. J. Ferreiro
11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
11:07
Houston Methodist DeBakey Heart and Vascular Center

Aspirin & Primary Prevention: What Do the Guidelines Say?

Feat. M. Gulati
15:09
Houston Methodist DeBakey Heart and Vascular Center

Plaque Burden Is the Main Driver of Risk for Atherosclerotic Events:…

Feat. M. Mortensen
13:58
Houston Methodist DeBakey Heart and Vascular Center

CAC Score for Aspirin Allocation

Feat. M. Cainzos-Achirica
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
08:24
Houston Methodist DeBakey Heart and Vascular Center

Cardiovascular Disease Prevention During the COVID-19 Pandemic

Feat. E. Duffy
09:01
Houston Methodist DeBakey Heart and Vascular Center

The Question on Everyone's Mind: What IS and Why Do We Need Pre…

Feat. M. Shapiro
05:23
Houston Methodist DeBakey Heart and Vascular Center

Strategies for Preventing Myocardial Infarction

Feat. R. Blankstein
06:45
Houston Methodist DeBakey Heart and Vascular Center

Community and Social Context: An Important Social Determinant of Car…

Feat. Z. Javed
08:23
Houston Methodist DeBakey Heart and Vascular Center

Aspirin in the Modern Era of Cardiovascular Disease Prevention

Feat. M. Cainzos-Achirica
06:08
Houston Methodist DeBakey Heart and Vascular Center

Past, Present and Future of Familial Hypercholesterolemia Management

Feat. K. Patel
06:12
Houston Methodist DeBakey Heart and Vascular Center

Prevention Starts in the Womb: Opportunities for Addressing Cardiova…

Feat. E. Avenatti
04:05
Houston Methodist DeBakey Heart and Vascular Center

A Checklist Approach for Enhanced Outpatient Guideline-Directed Mana…

Feat. M. Taha
03:11
Houston Methodist DeBakey Heart and Vascular Center

Q&A: Cardiovascular Disease Prevention

Feat. M. Cainzos-Achirica, M. Quiñones
13:25
Houston Methodist DeBakey Heart and Vascular Center

Medical Management of Obesity: The Future Is Bright

Feat. M. Taha
16:37
Houston Methodist DeBakey Heart and Vascular Center

Current and Emerging Options in Lipid Management

Feat. R. Santos
17:01
Houston Methodist DeBakey Heart and Vascular Center

Hypertension Management: Greater Returns Than Expected in CVD Preven…

Feat. S. Juraschek
10:59
Houston Methodist DeBakey Heart and Vascular Center

Q&A: Management of Atherosclerosis, Diabetes, Obesity and Hypert…

Feat. K. Patel, M. Taha, S. Juraschek, R. Santos, K. Jha
16:16
Houston Methodist DeBakey Heart and Vascular Center

Hypertensive Disorders of Pregnancy: New Insights into CVD Prevention

Feat. G. Sharma
16:10
Houston Methodist DeBakey Heart and Vascular Center

ASCVD Risk in People of South Asian Ethnicity: What Is New in 2021?

Feat. M. Cainzos-Achirica
16:01
Houston Methodist DeBakey Heart and Vascular Center

Inflammatory Conditions: Fueling Risk for Premature CVD

Feat. N. Mehta
13:22
Houston Methodist DeBakey Heart and Vascular Center

CVD Prevention Considerations Among Those With Low Testosterone

Feat. M. Budoff
06:06
Houston Methodist DeBakey Heart and Vascular Center

Q&A: High-Risk Groups for CVD

Feat. N. Mehta, G. Sharma, M. Budoff
16:20
Houston Methodist DeBakey Heart and Vascular Center

How Do I Assess and Manage Statin Intolerance?

Feat. M. Shapiro
29:27
Houston Methodist DeBakey Heart and Vascular Center

Stress Reduction: Does It Matter?

Feat. I. Basu-Ray
11:59
Houston Methodist DeBakey Heart and Vascular Center

What Dietary Advice Should I Give to My Patients With CVD?

Feat. D. Belardo
16:53
Houston Methodist DeBakey Heart and Vascular Center

Ideal Cardiovascular Health: What We Should Be Aiming for

Feat. J. Rana
05:02
Houston Methodist DeBakey Heart and Vascular Center

Q&A: Statins and Nutrition

Feat. M. Shapiro, M. Gulati, D. Belardo, J. Rana
06:59
Houston Methodist DeBakey Heart and Vascular Center

Treatment of Type 2 Diabetes and Kidney Disease: Comparison of FIDEL…

Feat. G. Bakris
14:24
Houston Methodist DeBakey Heart and Vascular Center

Cardiovascular and Renal Outcomes With Efpeglenatide in Type 2 Diabe…

Feat. I. Lingvay
17:12
Houston Methodist DeBakey Heart and Vascular Center

Starting With Risk Factors and Biomarkers to Identify Patients for S…

Feat. A. Marie Navar
16:25
Houston Methodist DeBakey Heart and Vascular Center

Atherosclerosis Imaging: Major Role in Risk Assessment and Management

Feat. R. Blankstein
13:56
Houston Methodist DeBakey Heart and Vascular Center

Genetics: New Kid on the Block for Cardiovascular Disease Prediction

Feat. A. Khera
12:00
Houston Methodist DeBakey Heart and Vascular Center

Emerging Consideration in CVD Risk Assessment: Social Determinants o…

Feat. K. Nasir
18:32
Houston Methodist DeBakey Heart and Vascular Center

Q&A: Four Pillars of CVD Prevention

Feat. S. Virani, A. Marie Navar, R. Blankstein, K. Nasir, A. Khera
13:54
Houston Methodist DeBakey Heart and Vascular Center

Beyond Atherosclerotic CVD: Prevention of Heart Failure

Feat. K. Patel
17:15
Houston Methodist DeBakey Heart and Vascular Center

Practical Tips for Managing CVD Risk Among High-Risk Diabetes

Feat. M. Blaha
04:33
Houston Methodist DeBakey Heart and Vascular Center

Novel Treatment Targets in Pulmonary Arterial Hypertension

Feat. A. Tonelli
06:38
Houston Methodist DeBakey Heart and Vascular Center

Management of Group 2 Pulmonary Arterial Hypertension

Feat. J. Vachiéry, M. Quiñones
06:42
Houston Methodist DeBakey Heart and Vascular Center

Management of PH Due to Chronic Lung Disease

Feat. J. Weatherald
12:23
Houston Methodist DeBakey Heart and Vascular Center

The Evolution of Risk in PAH

Feat. R. Benza, S. Murthy
09:01
Houston Methodist DeBakey Heart and Vascular Center

Evaluation and Management of Congenital Heart Disease Associated Wit…

Feat. V. Duarte
06:55
Houston Methodist DeBakey Heart and Vascular Center

Chronic Thromboembolic Pulmonary Hypertension: Medical Management

Feat. Z. Safdar
06:15
Houston Methodist DeBakey Heart and Vascular Center

Approach to Team-Based Cardiometabolic Care

Feat. N. Pagidipati
17:43
Houston Methodist DeBakey Heart and Vascular Center

Q&A: CVD Prevention in Diabetes

Feat. G. Bakris, K. Patel, A. Kansara, I. Lingvay, N. Pagidipati
22:49
Houston Methodist DeBakey Heart and Vascular Center

Antithrombotic Medication Management: How to Redesign the Delivery Model t…

Feat. G. Barnes
11:39
Houston Methodist DeBakey Heart and Vascular Center

Medical Management of Peripheral Artery Disease: What Are the Risk F…

Feat. M. Creager
35:04
Houston Methodist DeBakey Heart and Vascular Center

Peripheral Artery Disease: What Are the Recommended Therapies? What …

Feat. M. Creager
08:11
Houston Methodist DeBakey Heart and Vascular Center

Broadening the Traditional Role Of the Anticoagulation Clinic: How Can The…

Feat. G. Barnes
11:45
Houston Methodist DeBakey Heart and Vascular Center

Dosage Management at the Anticoagulation Clinic: Is There a Way to Use EHR…

Feat. G. Barnes
43:44
Houston Methodist DeBakey Heart and Vascular Center

Predicting Progression of CVD and Cognitive Dysfunction in Childhood…

Feat. V. Fuster
11:19
Houston Methodist DeBakey Heart and Vascular Center

Diversity in Medicine: Are There Racial Differences in Treatment Out…

Feat. C. Yancy
13:12
Houston Methodist DeBakey Heart and Vascular Center

Peripheral Artery Disease: What Are the Risk Factors for Developing …

Feat. M. Creager
09:52
Houston Methodist DeBakey Heart and Vascular Center

Lipid Lowering Drugs for PAD: How Efficient Are Statins and PCSK9 In…

Feat. M. Creager
23:40
Houston Methodist DeBakey Heart and Vascular Center

Antithrombotic Therapies for PAD: How Effective Are Aspirin, Ticagre…

Feat. M. Creager
22:34
Houston Methodist DeBakey Heart and Vascular Center

Antithrombotic Medication Management: How Long Is the Anticoagulatio…

Feat. G. Barnes
08:11
Houston Methodist DeBakey Heart and Vascular Center

Broadening the Anticoagulation Clinic Role: How Efficient Is Aspirin…

Feat. G. Barnes
11:59
Houston Methodist DeBakey Heart and Vascular Center

Antithrombotic Medication Management: How to Dose DOAC and Prevent A…

Feat. G. Barnes
17:38
Houston Methodist DeBakey Heart and Vascular Center

Novel Use of Anti-Diabetic Drugs in Heart Failure: How Do SGLT2 Inhi…

Feat. D. J. Hamilton, I. Hussain, A. Bhimaraj
06:41
Houston Methodist DeBakey Heart and Vascular Center

What Is the Mechanism of Action of New Anti-Diabetic Drugs in Cardio…

Feat. D. J. Hamilton, A. Bhimaraj, I. Hussain
09:31
Houston Methodist DeBakey Heart and Vascular Center

Novel Use of Anti-Diabetic Drugs in Heart Failure: What Are the Bene…

Feat. D. J. Hamilton
08:44
Houston Methodist DeBakey Heart and Vascular Center

What Is the Role of Novel Anti-Diabetic Drugs in Cardiovascular Dise…

Feat. I. Hussain
04:39
Houston Methodist DeBakey Heart and Vascular Center

How Does Diabetes Cause Heart Failure?

Feat. I. Hussain
09:13
Houston Methodist DeBakey Heart and Vascular Center

SCAD & Pregnancy: What Is It, What Are the Causes, and When Does…

Feat. M. Tweet
11:40
Houston Methodist DeBakey Heart and Vascular Center

What CVD Risks Are Associated With Adverse Pregnancy Outcomes and Pr…

Feat. G. Sharma
07:39
Houston Methodist DeBakey Heart and Vascular Center

Familial Hypercholesterolemia & Pregnancy: Do We Need to Stop St…

Feat. L. Mehta
10:16
Houston Methodist DeBakey Heart and Vascular Center

What Are the Sex Differences in COVID-19 Pandemic Outcomes, and Impl…

Feat. G. Sharma
10:20
Houston Methodist DeBakey Heart and Vascular Center

How to Reconcile Sex Differences in CVD Prevention?

Feat. M. Gulati
12:38
Houston Methodist DeBakey Heart and Vascular Center

Cardiovascular Complications in Pregnancy: What Are the Risk Indicat…

Feat. N. Scott
11:44
Houston Methodist DeBakey Heart and Vascular Center

Genetic Markers of CVD Risk: What Are the Benefits of Genetic Testin…

Feat. C. Ballantyne
11:59
Houston Methodist DeBakey Heart and Vascular Center

What Is the Role of Lipids and Inflammation Biomarkers in Residual R…

Feat. L. Sperling
11:59
Houston Methodist DeBakey Heart and Vascular Center

Does Measuring and Lowering Lp(a) Affect CVD Risk Reduction?

Feat. R. Blankstein
12:46
Houston Methodist DeBakey Heart and Vascular Center

How Does Stress Increase the Risk of Cardiovascular Disease?

Feat. K. M. Chinnalyan
12:08
Houston Methodist DeBakey Heart and Vascular Center

Are All Carbs and Fats Created Equally, and What Influence Do Differ…

Feat. A. Agatston
10:37
Houston Methodist DeBakey Heart and Vascular Center

How Can Intensive Cardiac Rehabilitation Help Your Patients?

Feat. P. Taub
10:41
Houston Methodist DeBakey Heart and Vascular Center

2020 High Blood Pressure Guidelines: When Is BP Too High?

Feat. A. Marie Navar
07:11
Houston Methodist DeBakey Heart and Vascular Center

Who Should Get a Coronary Artery Calcium Test?

Feat. K. Nasir
13:19
Houston Methodist DeBakey Heart and Vascular Center

What Are the Key Components of Primary CVD Prevention from ACC/AHA G…

Feat. S. Virani
10:43
Houston Methodist DeBakey Heart and Vascular Center

Why and Who Needs to See a Preventive Cardiologist?

Feat. M. Shapiro
12:05
Houston Methodist DeBakey Heart and Vascular Center

How to Identify and Intervene on Heart Failure Risk Factors?

Feat. S. Khan
11:06
Houston Methodist DeBakey Heart and Vascular Center

PCSK9 Inhibitors & New Era in Lipid-Lowering Therapy: What Are t…

Feat. K. Nasir
24:20
Houston Methodist DeBakey Heart and Vascular Center

Past, Present, and Future of Familial Hypercholesteremia Management …

Feat. D. Rader
16:40
Houston Methodist DeBakey Heart and Vascular Center

Update on Inflammation & Atherosclerosis Treatment: Should All A…

Feat. P. Ridker
40:14
Houston Methodist DeBakey Heart and Vascular Center

New Insights About Inflammation & Atherosclerosis: Can Targeted …

Feat. P. Ridker
10:38
Houston Methodist DeBakey Heart and Vascular Center

Is a Vaccine for LDL a Realistic Option for the Future of CVD? Is Li…

Feat. S. Virani, K. Nasir, H. Warraich, R. Blankstein
13:14
Houston Methodist DeBakey Heart and Vascular Center

Prevention of MIs and Stroke: How to Screen and Stratify Risks in th…

Feat. S. Virani, K. Nasir, H. Warraich, R. Blankstein
12:34
Houston Methodist DeBakey Heart and Vascular Center

How Does Recreational Drug Use Influence the Risk Score for Stroke i…

Feat. S. Virani, K. Nasir, H. Warraich, R. Blankstein
12:43
Houston Methodist DeBakey Heart and Vascular Center

How to Reduce the Risks of a Repeat MI in the Young? What Are the 5 …

Feat. S. Virani, K. Nasir, H. Warraich, R. Blankstein
12:17
Houston Methodist DeBakey Heart and Vascular Center

Emerging Epidemics of Acute MI & Stroke in the Young: How to Bat…

Feat. S. Virani, K. Nasir, H. Warraich, R. Blankstein